Sana Biotechnology Inc (NASDAQ: SANA) on Friday, plunged -6.56% from the previous trading day, before settling in for the closing price of $2.59. Within the past 52 weeks, SANA’s price has moved between $2.55 and $12.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 17.94%. With a float of $122.07 million, this company’s outstanding shares have now reached $197.86 million.
The extent of productivity of a business whose workforce counts for 328 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sana Biotechnology Inc is 45.33%, while institutional ownership is 53.23%. The most recent insider transaction that took place on Oct 21 ’24, was worth 180,807. Before that another transaction happened on Sep 24 ’24, when Company’s Director sold 150,000 for $4.08, making the entire transaction worth $612,570. This insider now owns 2,848,121 shares in total.
Sana Biotechnology Inc (SANA) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.35 earnings per share (EPS) for the period topping the consensus outlook (set at -0.4) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.94% per share during the next fiscal year.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Sana Biotechnology Inc (SANA) is currently performing well based on its current performance indicators. A quick ratio of 4.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.88 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
The latest stats from [Sana Biotechnology Inc, SANA] show that its last 5-days average volume of 2.04 million was inferior to 2.15 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 4.01%. Additionally, its Average True Range was 0.30.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 1.48%, which indicates a significant decrease from 4.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.10% in the past 14 days, which was lower than the 71.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.92, while its 200-day Moving Average is $6.49. Now, the first resistance to watch is $2.60. This is followed by the second major resistance level at $2.78. The third major resistance level sits at $2.90. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.17. Assuming the price breaks the second support level, the third support level stands at $1.99.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
Market capitalization of the company is 504.85 million based on 223,269K outstanding shares. Right now, sales total 0 K and income totals -283,260 K. The company made 0 K in profit during its latest quarter, and -59,920 K in sales during its previous quarter.
